Treatment of Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis of Clinical Outcomes

Abstract

Introduction: Subclinical hypothyroidism, defined by an elevated TSH with a normal free T4 level, is a common condition. Whether to treat it, particularly in older adults, is highly controversial. This review assesses the effects of levothyroxine therapy on clinical outcomes.

Methods: We conducted a systematic search for placebo-controlled RCTs that evaluated levothyroxine treatment in non-pregnant adults with subclinical hypothyroidism. Outcomes included quality of life, thyroid-related symptoms, and cardiovascular events.

Results: The meta-analysis of 21 RCTs, including a large individual patient data analysis, found that levothyroxine therapy did not result in significant improvements in quality of life or thyroid-related symptom scores compared to placebo. There was no evidence of a benefit on cardiovascular events or mortality.

Discussion: Despite effectively normalizing TSH levels, levothyroxine therapy does not appear to provide tangible clinical benefits for most patients with subclinical hypothyroidism. A watchful waiting approach may be appropriate for many, especially older adults with mild TSH elevations.

Conclusion: Levothyroxine therapy for subclinical hypothyroidism does not significantly improve quality of life or clinical symptoms.